Creative Planning’s Molina Healthcare MOH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $13.3M | Buy |
58,051
+20,569
| +55% | +$3.73M | 0.01% | 708 |
|
|
2026
Q1 | $5M | Buy |
37,482
+17,716
| +90% | +$2.82M | ﹤0.01% | 1203 |
|
|
2025
Q4 | $3.43M | Sell |
19,766
-15,859
| -45% | -$2.61M | ﹤0.01% | 1281 |
|
|
2025
Q3 | $6.82M | Buy |
35,625
+22,632
| +174% | +$4.17M | 0.01% | 726 |
|
|
2025
Q2 | $3.87M | Buy |
12,993
+718
| +6% | +$225K | ﹤0.01% | 888 |
|
|
2025
Q1 | $4.04M | Buy |
12,275
+494
| +4% | +$149K | ﹤0.01% | 797 |
|
|
2024
Q4 | $3.43M | Buy |
11,781
+3,327
| +39% | +$1.03M | ﹤0.01% | 827 |
|
|
2024
Q3 | $2.91M | Buy |
8,454
+226
| +3% | +$74.6K | ﹤0.01% | 876 |
|
|
2024
Q2 | $2.45M | Sell |
8,228
-603
| -7% | -$205K | ﹤0.01% | 906 |
|
|
2024
Q1 | $3.63M | Buy |
8,831
+1,976
| +29% | +$766K | ﹤0.01% | 721 |
|
|
2023
Q4 | $2.48M | Buy |
6,855
+1,071
| +19% | +$378K | ﹤0.01% | 824 |
|
|
2023
Q3 | $1.9M | Buy |
5,784
+870
| +18% | +$274K | ﹤0.01% | 866 |
|
|
2023
Q2 | $1.48M | Buy |
4,914
+1,472
| +43% | +$423K | ﹤0.01% | 944 |
|
|
2023
Q1 | $921K | Buy |
3,442
+714
| +26% | +$205K | ﹤0.01% | 1124 |
|
|
2022
Q4 | $901K | Sell |
2,728
-450
| -14% | -$153K | ﹤0.01% | 1086 |
|
|
2022
Q3 | $1.05M | Buy |
3,178
+186
| +6% | +$59.9K | ﹤0.01% | 949 |
|
|
2022
Q2 | $837K | Buy |
+2,992
| New | +$904K | ﹤0.01% | 1041 |
|
|
2021
Q2 | – | Sell |
-2,156
| Closed | -$504K | – | 2384 |
|
|
2021
Q1 | $504K | Sell |
2,156
-91
| -4% | -$20.3K | ﹤0.01% | 1436 |
|
|
2020
Q4 | $478K | Sell |
2,247
-6,950
| -76% | -$1.43M | ﹤0.01% | 1350 |
|
|
2020
Q3 | $1.68M | Buy |
9,197
+4,743
| +106% | +$863K | ﹤0.01% | 622 |
|
|
2020
Q2 | $793K | Buy |
4,454
+2,474
| +125% | +$421K | ﹤0.01% | 832 |
|
|
2020
Q1 | $277K | Buy |
1,980
+428
| +28% | +$57.3K | ﹤0.01% | 1210 |
|
|
2019
Q4 | $211K | Sell |
1,552
-5,094
| -77% | -$642K | ﹤0.01% | 1605 |
|
|
2019
Q3 | $729K | Buy |
6,646
+2,799
| +73% | +$363K | ﹤0.01% | 886 |
|
|
2019
Q2 | $551K | Sell |
3,847
-327
| -8% | -$44.8K | ﹤0.01% | 1023 |
|
|
2019
Q1 | $593K | Buy |
4,174
+1,673
| +67% | +$226K | ﹤0.01% | 951 |
|
|
2018
Q4 | $291K | Buy |
2,501
+527
| +27% | +$69.1K | ﹤0.01% | 1248 |
|
|
2018
Q3 | $294K | Buy |
+1,974
| New | +$252K | ﹤0.01% | 1411 |
|
|
2017
Q3 | – | Sell |
-278
| Closed | -$19K | – | 2997 |
|
|
2017
Q2 | $19K | Hold |
278
| – | – | ﹤0.01% | 3222 |
|
|
2017
Q1 | $13K | Sell |
278
-49
| -15% | -$2.56K | ﹤0.01% | 3429 |
|
|
2016
Q4 | $18K | Sell |
327
-451
| -58% | -$24.7K | ﹤0.01% | 3146 |
|
|
2016
Q3 | $45K | Sell |
778
-2,245
| -74% | -$124K | ﹤0.01% | 2444 |
|
|
2016
Q2 | $151K | Sell |
3,023
-160
| -5% | -$8.55K | ﹤0.01% | 1415 |
|
|
2016
Q1 | $205K | Buy |
3,183
+110
| +4% | +$6.53K | ﹤0.01% | 1201 |
|
|
2015
Q4 | $185K | Buy |
3,073
+178
| +6% | +$11.2K | ﹤0.01% | 1245 |
|
|
2015
Q3 | $199K | Buy |
+2,895
| New | +$215K | ﹤0.01% | 1196 |
|
|
2015
Q2 | – | Sell |
-199
| Closed | -$13K | – | 2264 |
|
|
2015
Q1 | $13K | Buy |
+199
| New | +$11.5K | ﹤0.01% | 3024 |
|
Other funds holding MOH
LIM
Creative Planning's MOH Position: Q2 2026 in Review
Creative Planning increased its Molina Healthcare (MOH) stake by 55% in Q2 2026, buying an estimated $3.73M and bringing the position to 58,051 shares worth $13.3M. The position accounts for 0.01% of the portfolio, ranked #708.
Creative Planning first reported a position in MOH in Q1 2015 and has held it in 37 quarters since. 601 funds tracked by Wall St. Rank hold MOH as of Q2 2026.
- Creative Planning held 58,051 shares of Molina Healthcare worth $13.3M as of Q2 2026.
- Creative Planning bought 20,569 Molina Healthcare shares in Q2 2026, an estimated $3.73M.
- Molina Healthcare made up 0.01% of Creative Planning's portfolio in Q2 2026, its #708 holding.
- Creative Planning first reported a position in Molina Healthcare in Q1 2015 and has held it in 37 quarters since.
- 601 funds tracked by Wall St. Rank held Molina Healthcare as of Q2 2026.
Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.